Your browser doesn't support javascript.
loading
Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria.
Xie, Xiao-Qing; Yang, Yi; Wang, Qiang; Liu, Hao-Fei; Fang, Xuan-Yu; Li, Cheng-Long; Jiang, Yi-Zhou; Wang, Shuai; Zhao, Hong-Yu; Miao, Jing-Ya; Ding, Shuai-Shuai; Liu, Xin-Dong; Yao, Xiao-Hong; Yang, Wen-Tao; Jiang, Jun; Shao, Zhi-Ming; Jin, Guoxiang; Bian, Xiu-Wu.
Affiliation
  • Xie XQ; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Yang Y; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Wang Q; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Liu HF; Department of Oncology, Shandong Second Provincial General Hospital, Jinan, Shandong, China.
  • Fang XY; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Li CL; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Jiang YZ; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Wang S; Department of Breast Surgery, Fudan University Shanghai Cancer Center; Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.
  • Zhao HY; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Miao JY; National Laboratory of Biomacromolecules, Chinese Academy of Sciences Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Ding SS; College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.
  • Liu XD; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Yao XH; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Yang WT; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Jiang J; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Shao ZM; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Jin G; Department of Breast Diseases, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Bian XW; Department of Breast Surgery, Fudan University Shanghai Cancer Center; Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.
Cell Res ; 33(3): 215-228, 2023 03.
Article in En | MEDLINE | ID: mdl-36627348
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B7-H1 Antigen / Mitophagy Limits: Humans Language: En Journal: Cell Res Year: 2023 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B7-H1 Antigen / Mitophagy Limits: Humans Language: En Journal: Cell Res Year: 2023 Document type: Article Affiliation country: China